« Back to Record
Vergote, I., Van Nieuwenhuysen, E., Casado, A., Laenen, A., Lorusso, D., Braicu, E. I., Guerra-Alia, E. M. E., Zola, P., Wimberger, P., Debruyne, P. P., Falcó, E., Ferrero, A., Muallem, M. Z., Kerger, J., García-Martinez, E., Pignata, S., Sehouli, J., van Gorp, T., Gennigens, C., & Rubio, M. J. (2023). Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer. Gynecologic oncology, 174, 80-88. doi:10.1016/j.ygyno.2023.04.028
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371600



